Barry K. Brown - 29 Mar 2022 Form 3 Insider Report for vTv Therapeutics Inc. (VTVT)

Role
Chief Accounting Officer
Signature
/s/ Elizabeth Keiley, as attorney-in-fact for Barry Brown
Issuer symbol
VTVT
Transactions as of
29 Mar 2022
Net transactions value
$0
Form type
3
Filing time
06 Mar 2023, 15:30:01 UTC
Next filing
11 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VTVT Class A common stock 100 29 Mar 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VTVT Employee stock option (right to buy) 29 Mar 2022 Class A common stock 10,000 $9.22 Direct F1
holding VTVT Employee stock option (right to buy) 29 Mar 2022 Class A common stock 9,149 $5.81 Direct F2
holding VTVT Employee stock option (right to buy) 29 Mar 2022 Class A common stock 10,000 $2.18 Direct F3
holding VTVT Employee stock option (right to buy) 29 Mar 2022 Class A common stock 20,000 $2.07 Direct F4
holding VTVT Employee stock option (right to buy) 29 Mar 2022 Class A common stock 200,000 $0.7100 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vests in equal annual installments over the three-year period beginning on September 9, 2015, subject to continued employment.
F2 Vests in equal annual installments over the three-year period beginning on March 10, 2017, subject to continued employment.
F3 Vests in equal annual installments over the three-year period beginning on March 7, 2019, subject to continued employment.
F4 Vests in equal annual installments over the three-year period beginning on December 7, 2020, subject to continued employment.
F5 Vests in equal annual installments over the three-year period beginning on February 17, 2022, subject to continued employment.

Remarks:

Exhibit 24: Power of Attorney